Latest filing published 01 Mar 2016 for Merrimack Pharmaceuticals INC, €10k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William M. McClements: trading record in brief
William M. McClements is a declared insider of Merrimack Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 27 November 2013 to 29 February 2016, the count stands at 7 filings.
No open-market sale appears; the market trades are 6 purchases worth €47k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2016: 1 purchase and no sales on the market.
The median purchase comes to €6,969.
The newest entry dates from 1 March 2016: an open-market purchase of €10k, in Merrimack Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William M. McClements
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$5.72100.0% of flowCommon StockSEC:0001209191-16-103780:0Canonical exit: 29 May 2016 (T+90)
- 928 sharesCommon StockSEC:0001209191-16-097385:0
- 1,500 shares@ US$4.05Common StockSEC:0001179110-13-017859:0Canonical exit: 11 Mar 2014 (T+90)
- 2,500 shares@ US$4.39Common StockSEC:0001179110-13-017859:1Canonical exit: 12 Mar 2014 (T+90)
- 2,000 shares@ US$4.06Common StockSEC:0001179110-13-017359:0Canonical exit: 2 Mar 2014 (T+90)
- 6,000 shares@ US$3.56Common StockSEC:0001179110-13-017228:0Canonical exit: 25 Feb 2014 (T+90)
- 1,000 shares@ US$3.91Common StockSEC:0001179110-13-017228:1Canonical exit: 27 Feb 2014 (T+90)
7 of 7 declarations
